Treatments & Interventions
Doxorubicin hydrochloride
substance
Doxorubicin
substance
Carboplatin
substance
Valrubicin
substance
Etoposide
substance
Cisplatin
substance
Mitomycin
substance
Thiotepa
substance
Oxaliplatin
substance
Daunorubicin hydrochloride liposome
substance
Etoposide phosphate
substance
Nivolumab
substance
Pembrolizumab
substance
Atezolizumab
substance
Doxorubicin hydrochloride pegylated liposome
substance
Enfortumab vedotin
substance
Related Conditions
Neoplasm of rectovesical septum(child)
Neoplasm of trigone of urinary bladder(child)
Neoplasm of apex of urinary bladder(child)
Neoplasm of lateral wall of urinary bladder(child)
Neoplasm of anterior wall of urinary bladder(child)
Neoplasm of posterior wall of urinary bladder(child)
Neoplasm of urinary bladder neck(child)
Neoplasm of ureteric orifice of urinary bladder(child)
Benign neoplasm of bladder(child)
Neoplasm of uncertain behavior of bladder(child)
Carcinoma in situ of bladder(child)
Malignant tumour of urinary bladder(child)
Neoplasm of dome of urinary bladder(child)
Tumor of urinary tract(parent)
Lesion of bladder(parent)
Neoplasm of pelvis(parent)
Neoplasm of intra-abdominal organs(parent)
Quick Facts
- SNOMED CT
- 126885006
- UMLS CUI
- C0005695
- Fully Specified Name
- Neoplasm of urinary bladder (disorder)
- Specialists
- 0
- Diagnostic Biomarkers
- 0
- Known Treatments
- 16
Medical Disclaimer
This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.
Clinical content is derived from the SNOMED CT clinical ontology and curated medical knowledge graphs.